Abstract
Background
There is a paucity on literature data related to conversion of Omega anastomosis gastric bypass (OAGB) to Roux-en-Y gastric bypass (RYGB).
Methods
This is a retrospective study. Records of all patients who underwent this conversion were analyzed. Additionally, patients were contacted to answer a questionnaire on their current clinical condition.
Results
Twenty-eight patients underwent laparoscopic conversion between September 2007 and June 2016. Indications were peritonitis in 7 patients (leaks after OAGB in 5, perforated marginal ulcer (MU) and blow-out remnant with concomitant leak in one patient each), anastomotic bleeding in one, bile reflux in 6, recalcitrant MU in 4, afferent loop syndrome in 6, postprandial vomiting in 2 (related to anastomotic stenosis and perianastomotic diverticulum, one each), and malnutrition and hypoglycemia both in 1. Thirty-day mortality was zero, complication rate (Clavien–Dindo grade III or more) 5% ((N = 1/20), abscess) when conversion was elective and 50.0% ((N = 4/8), all persisting leaks) when conversion was urgent. All 4 leaks persisting after conversion were successfully treated by endoscopic stenting, despite stent migration in 2 patients. Follow-up was available in 92.9%, for a mean time of 64.5 ± 30.1 months. Successful symptom relief (Likert score 4 or more) was noted for bile reflux and postprandial vomiting. Additionally, malnutrition was corrected.
Conclusions
When indicated, conversion of OAGB to RYGB is a safe treatment strategy. In case conversion is performed for leak after OAGB, persisting subclinical leaks are frequent but can be efficiently addressed by endoscopic stenting.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Robert Rutledge was the first to report on Omega (or one-) anastomosis gastric bypass (OAGB) as a bariatric procedure (1997) [1]. In 2014, OAGB accounted for 1.8% of the bariatric procedures worldwide [2]. Despite reports on excellent mid-term metabolic outcomes and 20 years of experience by now, there is no significant worldwide increase in numbers for this procedure [3,4,5]. OAGB is still perceived as controversial, because of the alleged predisposition for gastric and esophageal cancer, biliary reflux and gastritis, persistent marginal ulcers (MU), and malnutrition [6, 7]. Nevertheless, OAGB has been included in our department’s armamentarium in 2007 and last year accounted for 40% of our primary bariatric procedures, besides Roux-en-Y gastric bypass (RYGB) (30%), and sleeve gastrectomy (30%).
We were seduced by the simplicity of the OAGB procedure and hypothesized that in case patients did experience a side effect, conversion to RYGB would be straightforward and salutary.
In order to evaluate this hypothesis, we present here our experience with the conversion of OAGB to RYGB, with focus on the perioperative morbidity and the management of leaks persisting after this conversion.
Materials and methods
A retrospective chart analysis was conducted of all patients who underwent conversion from OAGB to RYGB. At our follow-up point (2017), we contacted all selected patients to reassess the condition that had demanded the conversion, and to check for possible reinterventions that might have been required in relation to the conversion. All patients were interviewed by telephone at our follow-up point and asked to score their symptom control on a 5-point Likert scale [8].
Our study was approved by the ethical committee of our hospital (nr B012201732939) and all patients consented in including their anonymized data in the study.
Patients had been selected for OAGB based on our bariatric algorithm (Online Appendix) and on the proceedings of the multidisciplinary consultation.
A long (> 10 cm) and narrow 30-ml gastric pouch was created and anastomosed end-to-side to the small bowel by semi-mechanical technique. The afferent limb was made some 200 cm long, provided the remaining (efferent) limb had a length of at least 300 cm. The Petersen defect was closed systematically. Early in our experience in selected patients we added a Nissen-Rossetti-type fundoplication using the remnant fundus, in an effort to prevent reflux and to reinforce the hiatal repair when performed.
Technique of conversion to RYGB
Depending on the peroperative findings and indication, we used three different techniques, in growing order of complexity (Fig. 1):
-
a.
Lonroth technique (keeping the anastomosis): section of the small bowel (afferent limb) just proximal to the gastro-enteral anastomosis (GE), reanastomosing the small bowel to the efferent limb 60 cm distal to the GE.
-
b.
Separation of the anastomosis (without small bowel resection): transection of the anastomosis flush with the staple line, with care to avoid lumen stenosis, shortening of the gastric pouch, new GE proximal on the small bowel to the previous anastomosis, and completion of the Roux-en-Y.
-
c.
Resection of the entire anastomosis: section of the gastric side to create a shorter gastric pouch and section of the afferent and efferent bowel side, removal of the isolated specimen, restoration of bowel continuity, new GE and completion of the Roux-en-Y.
The previously closed Petersen defects were checked, the newly created mesenteric defects systematically closed, and a drain placed in the vicinity of the GE.
If present, the Nissen-Rossetti fundoplication was taken down and, when no overt sepsis was present, a polar remnant gastrectomy was performed.
Indications for conversion
Were considered an indication for conversion of OAGB to RYGB:
-
1.
Early conversions:
-
all postoperative leaks after OAGB with ongoing sepsis despite maximal conservative therapy (i.e., antibiotics, resuscitation)
-
anastomotic bleeding with hemodynamic instability.
-
-
2.
Late conversions:
-
clinically severe reflux, i.e., frequent (more than once weekly) self-reported bile vomiting, or gastroesophageal reflux suffered at least daily and proven to be bilious on endoscopy; symptoms persist despite conservative treatment including prokinetics and elevation of the bedhead
-
endoscopically proven MU, persisting despite at least 3 months of conservative measures consisting of high-dose Proton Pump Inhibitors (PPI) and other oral antacid medications. Possible causative factors such as gastrogastric fistula had to have been ruled out.
-
Afferent loop syndrome: severe gastrointestinal symptoms such as bloating experienced as invalidating abdominal distension and diarrhea that remain unresponsive to conservative measures including strict dietary guidelines, trial with antibiotic therapy and digestive enzymes.
-
malnutrition, i.e., protein malnutrition with plasma protein under 5 g/dl, unresponsive to dietary measures
-
neuroglycopenia, i.e., hypoglycemia in the context of the Whipple triad (symptomatic hypoglycemia resolving by normalization of plasma glucose levels), in the absence of insulin producing foci.
-
Endpoints
The primary endpoint of this study was the early and late morbidity of converting OAGB to RYGB. To quantify morbidity, the standardized Clavien–Dindo Classification system was used [9]. Complications graded III or over were registered. Special attention was paid to the incidence and treatment of post-conversion (persisting) leaks. Leaks were assessed by upper gastrointestinal tract contrast radiography and/or by methylene blue test when an intra-abdominal drain was still in place.
Secondary endpoint was the efficiency of the conversion in addressing the condition that had required the conversion after OAGB.
Statistics
Quantitative data are expressed as mean + standard deviation when normally distributed and as median + interquartile t-range (IQR) when distribution was not Gaussian.
Results
Of the 526 patients with obesity who underwent an OAGB at our institution between September 2007 and June 2016, 28 (5.3%) underwent conversion to a RYGB construction at our department: 7 for an early and 21 for a late postoperative complication. The latter group included 1 MU perforation, and hence in total 8 patients required urgent treatment (Fig. 2). All conversions were completed laparoscopically. An overview of relevant patients’ characteristics, operative details of the OAGB, and conversion procedure and indications are reported in Table 1.
Of note, in 3 of 6 patients with an afferent loop syndrome a “Nissen-Rossetti-type” fundoplication had been performed during the primary OAGB procedure.
Table 2 provides the operative details of the conversion procedure. Eighteen patients (64.3%) benefited from the Lonroth technique (technique A), including the 5 individuals who suffered an acute leak shortly after OAGB, i.e., on postoperative day 1, 2, 6, 7, and 8, respectively.
No post-conversion mortality was noted. The overall 30-day postoperative complication rate was 5/28 (17.9%), including 4 persisting leaks for the 8 patients who had undergone the conversion as an emergency (50%). The fifth suffered an abscess after elective conversion for therapy resistant MU and was an active smoker at time of conversion. Additionally, one patient was affected by a severe hemodynamic shock after OAGB related to biliary limb bleeding for which urgent conversion and prolonged intensive care unit (ICU) stay was needed without observing conversion-related complications. The remaining 19 of the 20 patients (95%) who underwent elective conversion benefited from an uncomplicated early postoperative course (Fig. 2).
The persisting leaks occurring after conversion were treated by mantling the defect with a partially covered self-expandable metallic stent (SEMS) (Ultraflex°, Boston Scientific, Natick MA), which was kept in situ for between 2 and 6 weeks, followed by the insertion of a plastic stent before extraction 1 week later (Polyflex°, Boston Scientific, Natick MA) (Fig. 3). This stenting strategy proved successful in all 4 patients, with resolution of the leak. However, 2 patients (50%) required an additional endoscopic stenting procedure because of stent migration.
Follow-up was available in 26 patients (92.9%) after a mean time of 64.5 ± 30.1 months; one patient could not be traced, and one other individual preferred not to participate.
The evolution of the condition that had led to conversion was assessed at our follow-up point and is summarized in Table 3. In particular, for the individuals suffering from bile reflux, postprandial vomiting or MU outcome was good (Likert score of 4 or 5), except in one patient who peroperatively appeared to suffer a MU that had perforated toward the pancreas. The patient operated on for malnutrition regained 11.9 points of BMI, and total protein rose to 6.7 g/dl at follow-up.
Table 4 lists patients’ additional postoperative abdominal interventions after conversion.
Discussion
This study evaluated the safety of our conversion strategy from OAGB to RYGB, including our approach to possible postoperative complications after conversion. Conversion from OAGB to RYGB was performed either as an urgent salvage strategy or as an elective corrective procedure.
All but one (i.e., 7 of 8) urgent conversions were performed for a complication (i.e., 5 leaks, 1 blow-out of the remnant, and 1 bleeding) shortly after OAGB in a hemodynamically unstable patient. The eighth urgent conversion was performed in a patient suffering a perforated MU occurring 4 months after OAGB. Conversion to RYGB results in diverting the caustic biliopancreatic juices away from the defective anastomosis. In our experience, urgent conversion to RYGB did provide eventual sepsis control in all 6 patients thus treated. In comparison, Poghosyan and Beaupel et al. noted an uncomplicated conversion to RYGB in the treatment of similar leaks in 2/3 (need for additional stenting in just one) and 2/2 patients [10, 11]. Along the same lines, Genser et al. reported ongoing leaks after their technique of revision, consisting of peritoneal wash-out with suturing of the defect and omentoplasty, in 2/4 patients with need for a second laparoscopic drainage in one patient [12].
In our experience, persisting leaks after conversion could successfully be managed thanks to stenting and percutaneous puncture of collections. Nevertheless, we did observe stent migration in two patients. Stent migration, along with stent intolerance, is a well-documented issue, but this complication does not seem to prevent the growing success of stent treatment for leaks after foregut surgery [13,14,15,16,17]. To minimize the risk of migration and allow early oral feeding, we advise partially covered self-expanding metallic stents [18]. We preconize a two-step removal strategy by introducing a plastic stent initially because of fear of complications in the one-step procedure (e.g., inversion technique) [19].
When conversion was performed electively, early postoperative outcome was excellent (uneventful postoperative course in 19/20 patients). Our numbers compared favorably with Poghosyan et al. who reported a surgical complication rate of 40.0% after conversion for late complications after OAGB [10]. Actually, the only patient who suffered a complication after elective conversion appeared to be a smoker, which constitutes a known risk factor for complications after bariatric surgery [20].
The chronic conditions that in our opinion justified elective conversion included bile reflux, MU, afferent loop syndrome, postprandial vomiting (anastomotic stenosis–perianastomotic diverticulum), malnutrition, and hypoglycemic syndrome.
Bile reflux is a rare but disabling, long-term complication after OAGB. The incidence appears to be less than 1% as reported by Musella et al. [6, 21]. Despite meticulous care in creating a narrow and long gastric tube, in our experience 1.1% (6 patients) needed conversion because of this condition. Our preferred treatment strategy is conversion by using a Lonroth technique, rather than a Braun jejunojejunostomy as described by Johnson et al. [22]. The Lonroth technique was effective in controlling bile reflux in all 4 patients available for follow-up. Poghosyan et al. reported a same efficiency of this procedure in three converted patients [10].
The incidence of MU after OAGB is reported to be around 5.6%, comparable to RYGB [7, 23, 24]. Treatment with high dose of PPI and elimination of risk factors seems to be efficient, translated in the low incidence of MU-related complications [3]. In the rare cases of treatment recalcitrant or complicated (perforated) MU, we prefer to convert to RYGB and proceed with shortening of the gastric pouch, resection of the anastomosis, and performance of a new semi-stapled anastomosis without vagotomy (technique C). This approach that includes shortening of the stomach pouch is based on the findings of Edholm et al. indicating that the relative risk of marginal ulcer increases by 14% for each additional cm length [25]. Additionally, anatomical abnormalities must be corrected as encountered during the conversion procedure [26, 27].
Bloating associated with diarrhea may be an expression of the afferent loop syndrome, a known complication after the Billroth II procedure. This condition is caused by inadequate evacuation of digestive juices from the biliopancreatic limb resulting in bacterial overgrowth and a clinical presentation of bloating [28]. Obviously, anatomic factors that facilitate stasis should be addressed during re-exploration, and hence the consent form for conversion for bloating/afferent loop syndrome and postprandial vomiting should mention the authorization to fully explore and correct any unexpected (sub)obstructive anatomical flaws such as the perianastomotic diverticulum that had gone undetected in our patient. Additionally, by systematically taking down the Nissen-Rossetti construction—if present—during the conversion procedure, we corrected this possible aggravating factor in the context of the afferent loop syndrome/bloating. After noticing effectiveness of this strategy in addressing bloating in OAGB patients, we avoided all Nissen-Rossetti constructions during primary OAGB in our subsequent cases.
Severe malnutrition is a feared long-term complication after OAGB [7]. Both the length of the common (which should be at least 300 cm) and biliopancreatic limb (maximum 150–200 cm) are crucial in terms of nutrient absorption, and the limb lengths should be corrected during the conversion procedure [3]. With limb length correction during the conversion procedure, the patient in our series gained 11.9 points of BMI after a follow-up period of 24 months. Poghosyan et al. reported a similar efficiency to address malnutrition after OAGB, with resolution (BMI > 18.5) in all 7 patients two years after conversion [10].
Concerning the one case of conversion to RYGB for hypoglycemia, this was based on the patient’s initial refusal to have the bypass construction reversed. By converting to RYGB, we aimed at constructing a bile-deprived (Roux) limb, where activation of the SGLT1 cotransporter does not occur and, consequently, active glucose absorption is impaired [29]. As a result, insulin hypersecretion and subsequent reactive hypoglycemia should be tapered [30]. The patient continued to experience invalidating hypoglycemic events, which was the reason to finally reverse her bypass anatomy on her request.
Limitations of our study are the retrospective character as well as the small sample size that are both sources of bias. In addition, we must regret the lack of objective endoscopic data at our follow-up point for the specific conditions bile reflux and MU.
Additional data analysis after OAGB is necessary to come to a standardization in the management of associated complications. In the meantime, as a rule, the less predictable outcome of the revisional procedure must be carefully discussed with the patient, as well as the higher postoperative morbidity compared to primary bariatric procedures [31].
In patients presenting with a complication after OAGB, conversion to a Roux-en-Y construction is a safe treatment option in the elective setting. Additionally, it is efficient in addressing early complications after OAGB, but at the expense of a high incidence of persistent leaks. Those can, however, be successfully approached by endoscopic stenting.
References
Rutledge R (2001) The mini-gastric bypass: Experience with the first 1,274 cases. Obes Surg 11:276–280
Angrisani L, Santonicola A, Iovino P, Vitiello A, Zundel N, Buchwald H, Scopinaro N (2017) Bariatric surgery and endoluminal procedures: IFSO Worldwide Survey 2014. Obes Surg 27(9):2279–2289
Chevallier JM, Arman GA, Guenzi M, Rau C, Bruzzi M, Beaupel N, Zinzindohoué F, Berger A (2015) One thousand single anastomosis (omega loop) gastric bypasses to treat morbid obesity in a 7-year period: outcomes show few complications and good efficiency. Obes Surg 25(6):951–958
Taha O, Abdelaal M, Abozeid M, Askalany A, Alaa M (2017) Outcomes of omega loop gastric bypass, 6-years experience of 1520 cases. Obes Surg 27(8):1952–1960
Milone M, Di Minno MN, Leongito M, Maietta P, Bianco P, Taffuri C, Gaudioso D, Lupoli R, Savastano S, Milone F, Musella M (2013) Bariatric surgery and diabetes remission: sleeve gastrectomy or mini-gastric bypass? World J Gastroenterol 19(39):6590–6597
Mahawar KK, Borg CM, Kular KS, Courtney MJ, Sillah K, Carr WRJ, Jennings N, Madhok B, Singhal R, Small PK (2017) Understanding objections to one anastomosis (mini) gastric bypass: a survey of 417 surgeons not performing this procedure. Obes Surg 27(9):2222–2228
Mahawar KK, Jennings N, Brown J, Gupta A, Balupuri S, Small PK (2013) “Mini” gastric bypass: systematic review of a controversial procedure. Obes Surg 23(11):1890–1898
Likert R (1932) A technique for the measurement of attitudes. Arch Psychol 140:1–55
Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240(2):205–213
Poghosyan T, Caille C, Moszkowicz D, Hanachi M, Carette C, Bouillot JL (2016) Roux-en-Y gastric bypass for the treatment of severe complications after omega-loop gastric bypass. Surg Obes Relat Dis 13(6):988–994
Beaupel N, Bruzzi M, Voron T, Nasser HA, Douard R, Chevallier JM (2017) Management of acute intra-abdominal sepsis caused by leakage after one anastomosis gastric bypass. Surg Obes Relat Dis 13(8):1297–1305
Genser L, Carandina S, Tabbara M, Torcivia A, Soprani A, Siksik JM, Cady J (2016) Presentation and surgical management of leaks after mini-gastric bypass for morbid obesity. Surg Obes Relat Dis 12(2):305–312
Chang J, Sharma G, Boules M, Brethauer S, Rodriquez J, Kroh MD (2016) Endoscopic stents in the management of anastomotic complications after foregut surgery: new applications and techniques. Surg Obes Relat Dis 12(7):1373–1381
Aryaie AH, Singer J, Fayezizadeh M, Lash J, Marks JM (2017) Efficacy of endoscopic management of leak after foregut surgery with endoscopic covered self-expanding metal stents (SEMS). Surg Endosc 31:612–617
Yimcharoen P, Heneghan HM, Tariq N, Brethauer SA, Kroh M, Chand B (2011) Endoscopic stent management of leaks and anastomotic strictures after foregut surgery. Surg Obes Rel Dis 7:628–636
Eubanks S, Edwards CA, Fearing NM, Ramaswamy A, de la Torre RA, Thaler KJ, Miedema BW, Scott JS (2008) Use of endoscopic stents to treat anastomotic complications after bariatric surgery. J Am Coll Surg 206(5):935–938
Donatelli G, Dhumane P, Perretta S, Dallemagne B, Vix M, Mutter D, Dritsas S, Doffoel M, Marescaux J (2012) Endoscopic placement of fully covered self expanding metal stents for management of post-operative foregut leaks. J Minim Access Surg 8(4):118–124
El Mourat H, Himpens J, Verhofstadt J (2013) Stent treatment for fistula after obesity surgery: results in 47 consecutive patients. Surg Endosc 27(3):808–816
Hill C, Khalil BK, Barola S, Agnihotri A, Moran RA, Chen YI, Ngamruengphong S, Singh VK, Frame LA, Schweitzer MA, Magnuson TH, Khashab MA, Okolo PI 3rd, Kumbhari V (2018) Inversion technique for the removal of partially covered self-expandable metallic stents. Obes Surg 28(1):161–168
Blair LJ, Huntington CR, Cox TC, Prasad T, Lincourt AE, Gersin KS, Heniford BT, Augenstein VA (2016) Risk factors for postoperative sepsis in laparoscopic gastric bypass. Surg Endosc 30(4):1287–1293
Musella M, Susa A, Greco F, De Luca M, Manno E, Di Stefano C, Milone M, Bonfanti R, Segato G, Antonino A, Piazza L (2014) The laparoscopic mini-gastric bypass: the Italian experience: outcomes from 974 consecutive cases in a multicenter review. Surg Endosc 28:156–163
Johnson WH, Fernanadez AZ, Farrell TM, Macdonald KG, Grant JP, McMahon RL, Pryor AD, Wolfe LG, DeMaria EJ (2007) Surgical revision of loop (“mini”) gastric bypass procedure: multicenter review of complications and conversions to Roux-en-Y gastric bypass. Surg Obes Relat Dis 3(1):37–41
Coblijn UK, Lagarde SM, de Castro SM, Kuiken SD, van Wagensveld BA (2015) Symptomatic marginal ulcer disease after Roux-en-Y gastric bypass: incidence, risk factors and management. Obes Surg 25:805–811
Lee WJ, Yu PJ, Wang W, Chen TC, Wei PL, Huang MT (2005) Laparoscopic Roux-en-Y versus mini-gastric bypass for the treatment of morbid obesity: a prospective randomized controlled clinical trial. Ann Surg 242:20–28
Edholm D, Ottosson J, Sundhom M (2016) Importance of pouch size in laparoscopic Roux-en-Y gastric bypass: a cohort study of 14.168 patients. Surg Endosc 30(5):2011–2015
Carr WR, Mahawar KK, Balupuri S, Small PK (2014) An evidence-based algorithm for the management of marginal ulcers following Roux-en-Y gastric bypass. Obes Surg 24(9):1520–1527
Chau E, Youn H, Ren-Fielding CJ, Fielding GA, Schwack BF, Kurian MS (2015) Surgical management and outcomes of patients with marginal ulcer after Roux-en-Y gastric bypass. Surg Obes Relat Dis 11(5):1071–1075
Kassir R, Blanc P, Lointier P, Breton C, Debs T, Tiffet O (2015) Laparoscopic revision of an Omega Loop Gastric Bypass to treat afferent loop syndrome. Obes Surg 25(10):1976–1978
Baud G, Raverdy V, Bonner C, Daoudi M, Caiazzo R, Pattou F (2016) Sodium glucose transport modulation in type 2 diabetes and gastric bypass surgery. Surg Obes Rel Dis 12:1206–1212
Himpens J, Vilallonga R, Cadière GB, Leman G (2016) Metabolic consequences of the incorporation of a Roux limb in an omega loop (mini) gastric bypass : evaluation by a glucose tolerance test at mid-term follow-up. Surg Endosc 30:2935–2945
Zhang L, Tan WH, Chang R, Eagon JC (2015) Perioperative risk and complications of revisional bariatric surgery compared to primary Roux-en-Y gastric bypass. Surg Endosc 29(6):1316–1320
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Disclosures
Dr. Himpens is a consultant with Ethicon Endosurgery and with Covidien (Medtronic). Dr. Bolckmans and Dr. Arman have no conflicts of interest or financial ties to disclose.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Bolckmans, R., Arman, G. & Himpens, J. Efficiency and risks of laparoscopic conversion of omega anastomosis gastric bypass to Roux-en-Y gastric bypass. Surg Endosc 33, 2572–2582 (2019). https://doi.org/10.1007/s00464-018-6552-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00464-018-6552-y